BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37088124)

  • 1. Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
    Anger HA; Raymond EG
    Contraception; 2023 Aug; 124():110055. PubMed ID: 37088124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "False positive" urine pregnancy test results after successful medication abortion.
    Raymond EG; Anger HA; Chong E; Haskell S; Grant M; Boraas C; Tocce K; Banks J; Kaneshiro B; Baldwin MK; Coplon L; Bednarek P; Shochet T; Platais I
    Contraception; 2021 Jun; 103(6):400-403. PubMed ID: 33596414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
    Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
    Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
    Anger HA; Raymond EG; Grant M; Haskell S; Boraas C; Tocce K; Banks J; Coplon L; Shochet T; Platais I; Winikoff B
    Contraception; 2021 Dec; 104(6):659-665. PubMed ID: 34329607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
    Chong E; Shochet T; Raymond E; Platais I; Anger HA; Raidoo S; Soon R; Grant MS; Haskell S; Tocce K; Baldwin MK; Boraas CM; Bednarek PH; Banks J; Coplon L; Thompson F; Priegue E; Winikoff B
    Contraception; 2021 Jul; 104(1):43-48. PubMed ID: 33781762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
    Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
    PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Goldberg AB; Fulcher IR; Fortin J; Hofer RK; Cottrill A; Dethier D; Gilbert A; Janiak E; Roncari D
    Obstet Gynecol; 2022 May; 139(5):771-780. PubMed ID: 35576336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
    Whitehouse KC; Shochet T; Lohr PA
    Contraception; 2022 Jun; 110():21-26. PubMed ID: 35259410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Gilbert AL; Gelfand D; Fortin J; Roncari D; Goldberg AB
    Contraception; 2023 Apr; 120():109955. PubMed ID: 36634731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
    Raymond EG; Tan YL; Grant M; Benavides E; Reis M; Sacks DN; Hannum C; Frapp S; Weaver MA
    Contraception; 2018 Apr; 97(4):324-328. PubMed ID: 29242085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
    Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
    Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.
    Raymond E; Chong E; Winikoff B; Platais I; Mary M; Lotarevich T; Castillo PW; Kaneshiro B; Tschann M; Fontanilla T; Baldwin M; Schnyer A; Coplon L; Mathieu N; Bednarek P; Keady M; Priegue E
    Contraception; 2019 Sep; 100(3):173-177. PubMed ID: 31170384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.
    Schmidt-Hansen M; Cameron S; Lohr PA; Hasler E
    Am J Obstet Gynecol; 2020 Jun; 222(6):551-563.e13. PubMed ID: 31715147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two home pregnancy tests for self-confirmation of medication abortion status: A randomized trial.
    Fok WK; Lerma K; Shaw KA; Blumenthal PD
    Contraception; 2021 Sep; 104(3):296-300. PubMed ID: 33992610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
    Raifman S; Ralph L; Biggs MA; Grossman D
    Reprod Health; 2021 May; 18(1):91. PubMed ID: 33947413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
    Moseson H; Jayaweera R; Egwuatu I; Grosso B; Kristianingrum IA; Nmezi S; Zurbriggen R; Bercu C; Motana R; Gerdts C
    Obstet Gynecol; 2023 Aug; 142(2):330-338. PubMed ID: 37411022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial.
    Paul M; Iyengar K; Iyengar S; Gemzell-Danielsson K; Essén B; Klingberg-Allvin M
    BMC Womens Health; 2014 Aug; 14():98. PubMed ID: 25127545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-sensitivity urine pregnancy testing to assess medical abortion outcome: A systematic review.
    Raymond EG; Shochet T; Bracken H
    Contraception; 2018 Jul; 98(1):30-35. PubMed ID: 29534996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis.
    Raymond EG; Shochet T; Blum J; Sheldon WR; Platais I; Bracken H; Dabash R; Weaver MA; Ngoc NTN; Blumenthal PD; Winikoff B
    Contraception; 2017 May; 95(5):442-448. PubMed ID: 28041991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.